References
- Fender AC, Rauch BH, Geisler T, Schrör K. Protease-Activated Receptor PAR-4: An Inducible Switch between Thrombosis and Vascular Inflammation? Thromb Haemost 2017;117:2013-2025.
- Fender AC, Wakili R, Dobrev D. Straight to the heart: Pleiotropic antiarrhythmic actions of oral anticoagulants. Pharmacol Res 2019;145:104257.
- Fender AC, Kleeschulte S, Stolte S, Leineweber K, Kamler M, Bode J, et al. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart. Basic Res Cardiol 2020;115:10.
- Kleeschulte S, Jerrentrup J, Gorski D, Schmitt J, Fender AC. Evidence for functional PAR-4 thrombin receptor expression in cardiac fibroblasts and its regulation by high glucose: PAR-4 in cardiac fibroblasts. Int J Cardiol 2018;252:163-166.
- Kolpakov MA, Guo X, Rafiq K, Vlasenko L, Hooshdaran B, Seqqat R, et al. Loss of Protease-Activated Receptor 4 Prevents Inflammation Resolution and Predisposes the Heart to Cardiac Rupture After Myocardial Infarction. Circulation 2020;142:758-775.
- Fontes JA, Rose NR, Čiháková D. The varying faces of IL-6: From cardiac protection to cardiac failure. Cytokine 2015;74:62-68.
- Ninh VK, Brown JH. The contribution of the cardiomyocyte to tissue inflammation in cardiomyopathies. Curr Opin Physiol 2021;19:129-134.
- Abbate A, Toldo S, Marchetti C, Kron J, Van Tassell BW, Dinarello CA. Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease. Circ Res 2020;126:1260-1280.
- Heijman J, Muna AP, Veleva T, Molina CE, Sutanto H, Tekook M, et al. Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Postoperative Atrial Fibrillation. Circ Res 2020;127:1036-1055.
- Yao C, Veleva T, Scott L, Jr., Cao S, Li L, Chen G, et al. Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation. Circulation 2018;138:2227-2242.
- Antoniak S, Owens AP, 3rd, Baunacke M, Williams JC, Lee RD, Weithäuser A, et al. PAR-1 contributes to the innate immune response during viral infection. J Clin Invest 2013;123:1310-1322.
- Chien PT, Lin CC, Hsiao LD, Yang CM. c-Src/Pyk2/EGFR/PI3K/Akt/CREB-activated pathway contributes to human cardiomyocyte hypertrophy: Role of COX-2 induction. Mol Cell Endocrinol 2015;409:59-72.
- Fender AC, Pavic G, Drummond GR, Dusting GJ, Ritchie RH. Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 2014;387:1001-1007.
- Mittendorff C, Abu-Taha I, Kassler L, Hustedt T, Wolf S, Bode JG, et al. Thrombin receptor PAR4 cross-activates the tyrosine kinase c-met in atrial cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 2025;398:2783-2796.
- Wang X, Xu Y, Li L, Lu W. Thrombin Aggravates Hypoxia/Reoxygenation Injury of Cardiomyocytes by Activating an Autophagy Pathway-Mediated by SIRT1. Med Sci Monit 2021;27:e928480.
- Rosenkranz AC, Schrör K, Rauch BH. Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells. Thromb Haemost 2011;106:561-562.
- Claycomb WC, Lanson NA, Jr., Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A, et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998;95:2979-2984.
- Kleeschulte S, Fischinger V, Öhlke L, Bode J, Kamler M, Dobrev D, et al. The thrombin receptor PAR4 supports visceral adipose tissue inflammation. Naunyn Schmiedebergs Arch Pharmacol 2024.
- Mann C, van Alst C, Gorressen S, Nega R, Dobrev D, Grandoch M, et al. Ischemia does not provoke the full immune training repertoire in human cardiac fibroblasts. Naunyn Schmiedebergs Arch Pharmacol 2024.
- d’Alessandro E, Becker C, Bergmeier W, Bode C, Bourne JH, Brown H, et al. Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis. Thromb Haemost 2020;120:538-564.
- Binder V, Ljubojevic S, Haybaeck J, Holzer M, El-Gamal D, Schicho R, et al. The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors. Arterioscler Thromb Vasc Biol 2013;33:1020-1027.
- Cao W, Xu J, Zhou ZM, Wang GB, Hou FF, Nie J. Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway. Antioxid Redox Signal 2013;18:19-35.
- Iwao Y, Nakajou K, Nagai R, Kitamura K, Anraku M, Maruyama T, et al. CD36 is one of important receptors promoting renal tubular injury by advanced oxidation protein products. Am J Physiol Renal Physiol 2008;295:F1871-1880.
- Pasterk L, Lemesch S, Leber B, Trieb M, Curcic S, Stadlbauer V, et al. Oxidized plasma albumin promotes platelet-endothelial crosstalk and endothelial tissue factor expression. Sci Rep 2016;6:22104.
- Noone D, Preston RJS, Rehill AM. The Role of Myeloid Cells in Thromboinflammatory Disease. Semin Thromb Hemost 2024.
- Halade GV, Lee DH. Inflammation and resolution signaling in cardiac repair and heart failure. EBioMedicine 2022;79:103992.
- Ghoshal K, Das S, Aich K, Goswami S, Chowdhury S, Bhattacharyya M. A novel sensor to estimate the prevalence of hypochlorous (HOCl) toxicity in individuals with type 2 diabetes and dyslipidemia. Clin Chim Acta 2016;458:144-153.
- Ulfig A, Leichert LI. The effects of neutrophil-generated hypochlorous acid and other hypohalous acids on host and pathogens. Cell Mol Life Sci 2021;78:385-414.
- Vlasova, II, Sokolov AV, Kostevich VA, Mikhalchik EV, Vasilyev VB. Myeloperoxidase-Induced Oxidation of Albumin and Ceruloplasmin: Role of Tyrosines. Biochemistry (Mosc) 2019;84:652-662.
- Neeland IJ, Ross R, Després JP, Matsuzawa Y, Yamashita S, Shai I, et al. Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement. Lancet Diabetes Endocrinol 2019;7:715-725.
- Chitongo PB, Roberts LN, Yang L, Patel RK, Lyall R, Luxton R, et al. Visceral Adiposity Is an Independent Determinant of Hypercoagulability as Measured by Thrombin Generation in Morbid Obesity. TH Open 2017;1:e146-e154.
- Prüller F, Raggam RB, Posch V, Almer G, Truschnig-Wilders M, Horejsi R, et al. Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation. Atherosclerosis 2012;220:215-218.